Full-Time

Cardiac Technician

Confirmed live in the last 24 hours

iRhythm Technologies

iRhythm Technologies

1,001-5,000 employees

Advanced cardiac monitoring solutions provider

Compensation Overview

$49.9k - $61.8k/yr

Junior

Highland Park, IL, USA

Must reside within 70 miles of Deerfield, IL. Hybrid role with 2 days/week in-office requirements.

Category
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a iRhythm Technologies referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • At least 1 year experience in healthcare, health insurance or medical device industry or prior experience in patient care, operations, lab setting and/or other diagnostic environment or an Associates degree or college course work in healthcare or life science related industry
  • High School Diploma required
  • PC agility skills and knowledge of Microsoft tools, windows, outlook
  • Successful completion of new hire training requirements
  • Knowledge of medical terminology specific to Cardiology
  • Able to be CCT certified within 120 days of hire (maximum 3 attempts)
  • Excellent attention to detail
  • Positive attitude and team player
  • Ability to use critical thinking skills
  • Demonstrated interest and desire to learn rhythm analysis and interpretation
  • Ability to define problems, collect data, establish facts, and draw valid conclusions
  • Excellent interpersonal, organizational, and communication skills
  • Must be open to continuous feedback for continual growth and development
  • Great work ethic and a desire to provide high quality outcomes (reports) to our clients and patients
Responsibilities
  • Review patient ECG data and algorithm findings for clinical accuracy, ensuring 100% data quality.
  • Effectively communicate ECG abnormalities to physicians as needed.
  • Perform quality assurance for every report, making necessary modifications before final delivery.
  • Continuously develop ECG interpretation skills, meeting productivity and quality metrics.
  • Maintain compliance with HIPAA guidelines and best clinical practices.
  • Read, interpret, and report on 90-second ECG strips with precision.
  • Provide quality assurance on reports for medical professionals and communicate critical findings clearly.
  • Follow up with patients for additional data transmissions.
  • Demonstrate strong ECG rhythm interpretation skills and uphold HIPAA guidelines.
  • Maintain proficiency requirements, ensuring timely certification.
Desired Qualifications
  • 2+ years’ experience as a cardiac telemetry monitor technician, Holter scanner or other position requiring ECG interpretation
  • RN, EMT, Exercise Physiologist, CCT, CRAT, EKG certification, CNA or equivalent training

iRhythm Technologies specializes in cardiac monitoring solutions, primarily through its product, the Zio Patch. This wearable device allows for up to 14 days of continuous heart rhythm tracking, enabling healthcare providers to detect irregular heart rhythms that shorter monitoring periods might miss. The Zio Patch is particularly useful for patients who suspect heart issues, as it allows them to monitor their heart activity without frequent visits to the doctor, which is especially important in the current telehealth environment. iRhythm serves both patients and healthcare providers, selling the Zio Patch and offering data analysis services to interpret the collected heart data. This approach helps improve patient outcomes and enhances the efficiency of healthcare delivery, setting iRhythm apart from competitors in the cardiac health market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

San Francisco, California

Founded

2006

Simplify Jobs

Simplify's Take

What believers are saying

  • Expansion into Europe could significantly boost international revenue streams.
  • FDA approval of Zio AT may increase market confidence and clinical adoption.
  • Growing global market for ambulatory cardiac monitoring supports iRhythm's growth potential.

What critics are saying

  • Shareholder investigation may lead to legal and financial repercussions for iRhythm.
  • FDA warning letter could increase regulatory scrutiny and operational costs.
  • International expansion poses risks related to regulatory compliance and market entry challenges.

What makes iRhythm Technologies unique

  • Zio Patch offers up to 14 days of uninterrupted cardiac monitoring.
  • iRhythm's integration with AI enhances predictive analytics for arrhythmia detection.
  • Partnership with BioIntelliSense expands multiparameter sensor technology in cardiac monitoring.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Mental Health Support

Hybrid Work Options

Pet Insurance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

2%
Life Care News
Apr 30th, 2025
iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

iRhythm Technologies to present at the Bank of America Securities 2025 Health Care Conference.

ETF Daily News
Mar 26th, 2025
Cibc World Markets Corp Invests $264,000 in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Cibc World Markets Corp invests $264,000 in iRhythm Technologies, Inc. (NASDAQ:IRTC).

Investing.com
Feb 28th, 2025
iRhythm technologies' CBO and CLO Murphy sells $1.79 million in stock

Additionally, iRhythm is expanding internationally, with early launches in Europe and plans to enter the Japanese market in mid-2025.

Yahoo Finance
Jan 13th, 2025
Irhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights And Business Update At The 43Rd Annual J.P. Morgan Healthcare Conference

iRhythmSAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 43rd Annual J.P. Morgan Healthcare Conference.Recent Operational Highlights and Financial OutlookAnticipate full year 2024 revenue slightly above high end of previously stated guidance range of $587.5 million provided in October 2024Record quarter of new account openings for both Zio monitor and Zio AT during the fourth quarter 2024 as well as strong volume contributions from large national accountsLaunched first four health care systems on Epic Aura during the fourth quarter 2024 with broad commercial roll out for Epic health systems across the U.S. beginning in 2025Initiated Zio monitor shipments for home enrollment patients during the fourth quarter 2024Five studies presented at the American Heart Association highlight Zio Monitor’s high patient satisfaction, engagement and compliance with the patient MyZio app and digital tools, health economic impact of early arrhythmia detection in type 2 diabetes and respiratory disease, and AI insights on sleep and activity patterns 1Expect revenue for the full year 2025 of approximately $675 million to $685 million“This past year was a period of significant growth and transformation for iRhythm,” said Quentin Blackford, iRhythm’s President and CEO. “In our core U.S

MarketBeat
Nov 26th, 2024
Dynamic Technology Lab Private Ltd Invests $1.50 Million in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Dynamic Technology Lab Private Ltd invests $1.50 million in iRhythm Technologies, Inc. (NASDAQ:IRTC).